CTNNB1 and hepatocellular carcinoma: Recent studies have found abnormal activation of the Wnt/β-catenin signaling axis in HCC carcinogenicity and that 44% of HCCs display gene alterations in the Wnt pathway, of which CTNNB1 mutation is increased up to 35% 29, 51.